Table 1.
Demographic characteristics of study populations.
| Test, n = 124 | Validation, n = 42 | p-value | |
|---|---|---|---|
| Patients with T2D | 69 (56%) | 11 (26%) | 0.001 |
| Sex (M/F) | 97 (78%)/27 (22%) | 30 (71%)/12 (29%) | 0.402 |
| Age, years | 62 ± 5 | 60 ± 10 | 0.105 |
| Height, m | 1.71 ± 0.8 | 1.70 ± 0.9 | 0.668 |
| Weight, kg | 83 ± 15 | 81 ± 18 | 0.435 |
| BMI, kg/m2 | 28.3 ± 4.1 | 27.7 ± 4.6 | 0.391 |
| Waist-hip ratio | 0.99 ± 0.11 | 0.99 ± 0.15 | 0.924 |
| Systolic BP, mmHg | 146 ± 21 | 138 ± 22 | 0.040 |
| Diastolic BP, mmHg | 80 ± 10 | 76 ± 9 | 0.053 |
| Current smokers | 13 (10%) | 8 (19%) | 0.180 |
| Depression score | 5.0 ± 5.0 | 5.3 ± 5.4 | 0.755 |
| HISTORY OF AMI | |||
| NSTEMI | 40 (32%) | 19 (45%) | 0.262 |
| STEMI | 24 (19%) | 11 (26%) | 0.384 |
| REVASCULARIZATION | |||
| PCI | 73 (59%) | 32 (76%) | 0.063 |
| CABG | 27 (22%) | 2 (5%) | 0.010 |
| CARDIAC FUNCTION | |||
| LVEF, % | 66 ± 8 | 65 ± 7 | 0.366 |
| LVMI | 101 ± 23 | 102 ± 23 | 0.804 |
| CCS class | 1.2 ± 0.4 | 1.3 ± 0.5 | 0.237 |
| PEAK EXERCISE TEST | |||
| Rest HR, bpm | 59 ± 9 | 60 ± 8 | 0.700 |
| Peak HR, bpm | 130 ± 19 | 132 ± 19 | 0.665 |
| Peak METs | 7.1 ± 1.9 | 7.1 ± 2.0 | 0.941 |
| Estimated peak mets | 7.2 ± 1.6 | 7.2 ± 1.7 | 0.788 |
| LABORATORY ANALYSES | |||
| HbA1c, % | 6.3 ± 0.8 | 6.1 ± 1.1 | 0.151 |
| Fasting plasma glucose, mmol/l | 6.3 ± 1.4 | 5.7 ± 1.1 | 0.021 |
| Total cholesterol, mmol/l | 4.0 ± 0.8 | 4.0 ± 0.9 | 0.609 |
| HDL cholesterol, mmol/l | 1.2 ± 0.3 | 1.3 ± 0.3 | 0.731 |
| LDL cholesterol, mmol/l | 2.3 ± 0.6 | 2.4 ± 0.8 | 0.154 |
| Triglycerides, mmol/l | 1.5 ± 0.9 | 1.5 ± 0.7 | 0.999 |
| MEDICATION | |||
| Oral antidiabetics | 57 (46%) | 10 (24%) | 0.012 |
| Insulin | 10 (8%) | 4 (10%) | 0.755 |
| Beta blockers | 108 (87%) | 35 (83%) | 0.606 |
| ACEI/ARB | 74 (60%) | 30 (71%) | 0.200 |
| Lipid lowering drugs | 114 (92%) | 40 (95%) | 0.732 |
| Anticoagulants | 121 (98%) | 41 (98%) | 0.989 |
| Calcium antagonists | 26 (21%) | 7 (17%) | 0.658 |
| Nitrates | 29 (23%) | 11 (26%) | 0.683 |
| Diuretics | 38 (31%) | 8 (19%) | 0.167 |